Sign In
24 Aug 2018 11:47
Collagen Solutions Plc
(the "Company" or the "Group")
Director/PDMR Dealing
The Company today announces that on 23 August 2018 Hilary Spence, Chief Financial Officer, purchased 220,000 Ordinary Shares at a purchase price of 4.50p.
Following these purchases, Hilary Spence holds 250,817 Ordinary Shares representing approximately 0.08 per cent of the Company's issued share capital.
The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Hilary Spence | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Financial Officer | ||||
b) | Initial notification / Amendment | Initial | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | COLLAGEN SOLUTIONS PLC | ||||
b) | LEI | 213800IFY1CVGRGETL95 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrumentIdentification code | Ordinary shares of 1p eachISIN: GB00B94T6Y14 | ||||
b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information- Aggregated volume- Price | N/A - single transaction | ||||
e) | Date of the transaction | 23 August 2018 | ||||
f) | Place of the transaction | London Stock Exchange, XLON | ||||
Enquiries:
Collagen Solutions Plc |
| ||
Jamal Rushdy, CEO | Via Walbrook | ||
Hilary Spence, CFO |
| ||
|
| ||
Cenkos Securities Plc (Nominated Adviser and Broker) |
| ||
Steve Cox (Corporate Finance) | Tel: 0207 397 8900 | ||
Stephen Keys |
| ||
|
| ||
Walbrook PR Ltd | Tel: 020 7933 8780 or collagen@walbrookpr.com | ||
Anna Dunphy | Mob: 07876 741 001 | ||
Helen Cresswell | Mob: 07841 917 679 | ||
Follow the stocks
